These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28468778)

  • 21. Development and Expansion of Patient-Derived Xenografts for Endometrial Cancer.
    Sengal AT; Pollock PM
    Methods Mol Biol; 2024; 2806():101-115. PubMed ID: 38676799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subrenal capsule grafting technology in human cancer modeling and translational cancer research.
    Wang Y; Wang JX; Xue H; Lin D; Dong X; Gout PW; Gao X; Pang J
    Differentiation; 2016; 91(4-5):15-9. PubMed ID: 26547391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
    Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
    J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients.
    Kim Y; Kim D; Cao B; Carvajal R; Kim M
    BMC Bioinformatics; 2020 Jul; 21(1):288. PubMed ID: 32631229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between tumor engraftment in patient-derived xenograft models and clinical outcomes in colorectal cancer patients.
    Oh BY; Lee WY; Jung S; Hong HK; Nam DH; Park YA; Huh JW; Yun SH; Kim HC; Chun HK; Cho YB
    Oncotarget; 2015 Jun; 6(18):16059-68. PubMed ID: 25965827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts.
    Cybulska M; Olesinski T; Goryca K; Paczkowska K; Statkiewicz M; Kopczynski M; Grochowska A; Unrug-Bielawska K; Tyl-Bielicka A; Gajewska M; Mroz A; Dabrowska M; Karczmarski J; Paziewska A; Zając L; Bednarczyk M; Mikula M; Ostrowski J
    Biomed Res Int; 2018; 2018():2954208. PubMed ID: 30662905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
    Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
    Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
    Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
    Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration.
    Fuchs V; Sobarzo A; Msamra M; Kezerle Y; Linde L; Sevillya G; Anoze A; Refaely Y; Cohen AY; Melamed I; Azriel A; Shoukrun R; Raviv Y; Porgador A; Peled N; Roisman LC
    Clin Transl Oncol; 2024 Sep; 26(9):2227-2239. PubMed ID: 38553659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.
    Izumchenko E; Paz K; Ciznadija D; Sloma I; Katz A; Vasquez-Dunddel D; Ben-Zvi I; Stebbing J; McGuire W; Harris W; Maki R; Gaya A; Bedi A; Zacharoulis S; Ravi R; Wexler LH; Hoque MO; Rodriguez-Galindo C; Pass H; Peled N; Davies A; Morris R; Hidalgo M; Sidransky D
    Ann Oncol; 2017 Oct; 28(10):2595-2605. PubMed ID: 28945830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-derived xenografts as in vivo models for research in urological malignancies.
    Inoue T; Terada N; Kobayashi T; Ogawa O
    Nat Rev Urol; 2017 May; 14(5):267-283. PubMed ID: 28248952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.
    Evans KW; Yuca E; Akcakanat A; Scott SM; Arango NP; Zheng X; Chen K; Tapia C; Tarco E; Eterovic AK; Black DM; Litton JK; Yap TA; Tripathy D; Mills GB; Meric-Bernstam F
    Clin Cancer Res; 2017 Nov; 23(21):6468-6477. PubMed ID: 29093017
    [No Abstract]   [Full Text] [Related]  

  • 33. Fidelity of a PDX-CR model for bladder cancer.
    Mondal AM; Ma AH; Li G; Krawczyk E; Yuan R; Lu J; Schlegel R; Stamatakis L; Kowalczyk KJ; Philips GK; Pan CX; Liu X
    Biochem Biophys Res Commun; 2019 Sep; 517(1):49-56. PubMed ID: 31303270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
    Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
    Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment and characterization of patient-derived xenograft and its cell line of primary leiomyosarcoma of bone.
    Oyama R; Takahashi M; Kito F; Sakumoto M; Shiozawa K; Qiao Z; Yoshida A; Endo M; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2018 Jun; 54(6):458-467. PubMed ID: 29845452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
    Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
    J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity.
    Brown KM; Xue A; Julovi SM; Gill AJ; Pavlakis N; Samra JS; Smith RC; Hugh TJ
    J Surg Res; 2018 Jul; 227():158-167. PubMed ID: 29804848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered colorectal cancer tissue recapitulates key attributes of a patient-derived xenograft tumor line.
    Hassani I; Anbiah B; Kuhlers P; Habbit NL; Ahmed B; Heslin MJ; Mobley JA; Greene MW; Lipke EA
    Biofabrication; 2022 Jul; 14(4):. PubMed ID: 35617932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.
    Jäger W; Xue H; Hayashi T; Janssen C; Awrey S; Wyatt AW; Anderson S; Moskalev I; Haegert A; Alshalalfa M; Erho N; Davicioni E; Fazli L; Li E; Collins C; Wang Y; Black PC
    Oncotarget; 2015 Aug; 6(25):21522-32. PubMed ID: 26041878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of Metastatic Cholangiocarcinoma Patient-Derived Xenograft Models.
    Yáñez-Bartolomé M; Serra-Camprubí Q; Arenas EJ; Escorihuela M; Castet F; Fabregat-Franco C; Querol J; Arribas J; Peiró S; Macarulla T; Tian TV
    Methods Mol Biol; 2024; 2806():139-151. PubMed ID: 38676801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.